Pharma BD Deal Intelligence
2004 · Acquisition/Merger · $1.9B · Complete
Announced mid-June 2004; $29.10/share cash; anti-infectives anidulafungin, dalbavancin; closed Sep 14 2005
← Browse all deals · How we score deals